Index
1 Recombinant Peptide Market Overview
1.1 Recombinant Peptide Product Overview
1.2 Recombinant Peptide Market Segment by Type
1.2.1 Glucagon
1.2.2 Calcitonin
1.2.3 Other
1.3 Global Recombinant Peptide Market Size by Type
1.3.1 Global Recombinant Peptide Market Size Overview by Type (2018-2029)
1.3.2 Global Recombinant Peptide Historic Market Size Review by Type (2018-2023)
1.3.3 Global Recombinant Peptide Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Recombinant Peptide Sales Breakdown by Type (2018-2023)
1.4.2 Europe Recombinant Peptide Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Recombinant Peptide Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Recombinant Peptide Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Recombinant Peptide Sales Breakdown by Type (2018-2023)
2 Global Recombinant Peptide Market Competition by Company
2.1 Global Top Players by Recombinant Peptide Sales (2018-2023)
2.2 Global Top Players by Recombinant Peptide Revenue (2018-2023)
2.3 Global Top Players by Recombinant Peptide Price (2018-2023)
2.4 Global Top Manufacturers Recombinant Peptide Manufacturing Base Distribution, Sales Area, Product Type
2.5 Recombinant Peptide Market Competitive Situation and Trends
2.5.1 Recombinant Peptide Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Recombinant Peptide Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Peptide as of 2022)
2.7 Date of Key Manufacturers Enter into Recombinant Peptide Market
2.8 Key Manufacturers Recombinant Peptide Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Recombinant Peptide Status and Outlook by Region
3.1 Global Recombinant Peptide Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Recombinant Peptide Historic Market Size by Region
3.2.1 Global Recombinant Peptide Sales in Volume by Region (2018-2023)
3.2.2 Global Recombinant Peptide Sales in Value by Region (2018-2023)
3.2.3 Global Recombinant Peptide Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Recombinant Peptide Forecasted Market Size by Region
3.3.1 Global Recombinant Peptide Sales in Volume by Region (2024-2029)
3.3.2 Global Recombinant Peptide Sales in Value by Region (2024-2029)
3.3.3 Global Recombinant Peptide Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Recombinant Peptide by Application
4.1 Recombinant Peptide Market Segment by Application
4.1.1 Oncology
4.1.2 Blood Disorders
4.1.3 Infectious Diseases
4.1.4 Autoimmune Diseases
4.1.5 Other
4.2 Global Recombinant Peptide Market Size by Application
4.2.1 Global Recombinant Peptide Market Size Overview by Application (2018-2029)
4.2.2 Global Recombinant Peptide Historic Market Size Review by Application (2018-2023)
4.2.3 Global Recombinant Peptide Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Recombinant Peptide Sales Breakdown by Application (2018-2023)
4.3.2 Europe Recombinant Peptide Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Recombinant Peptide Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Recombinant Peptide Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Recombinant Peptide Sales Breakdown by Application (2018-2023)
5 North America Recombinant Peptide by Country
5.1 North America Recombinant Peptide Historic Market Size by Country
5.1.1 North America Recombinant Peptide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Recombinant Peptide Sales in Volume by Country (2018-2023)
5.1.3 North America Recombinant Peptide Sales in Value by Country (2018-2023)
5.2 North America Recombinant Peptide Forecasted Market Size by Country
5.2.1 North America Recombinant Peptide Sales in Volume by Country (2024-2029)
5.2.2 North America Recombinant Peptide Sales in Value by Country (2024-2029)
6 Europe Recombinant Peptide by Country
6.1 Europe Recombinant Peptide Historic Market Size by Country
6.1.1 Europe Recombinant Peptide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Recombinant Peptide Sales in Volume by Country (2018-2023)
6.1.3 Europe Recombinant Peptide Sales in Value by Country (2018-2023)
6.2 Europe Recombinant Peptide Forecasted Market Size by Country
6.2.1 Europe Recombinant Peptide Sales in Volume by Country (2024-2029)
6.2.2 Europe Recombinant Peptide Sales in Value by Country (2024-2029)
7 Asia-Pacific Recombinant Peptide by Region
7.1 Asia-Pacific Recombinant Peptide Historic Market Size by Region
7.1.1 Asia-Pacific Recombinant Peptide Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Recombinant Peptide Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Recombinant Peptide Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Recombinant Peptide Forecasted Market Size by Region
7.2.1 Asia-Pacific Recombinant Peptide Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Recombinant Peptide Sales in Value by Region (2024-2029)
8 Latin America Recombinant Peptide by Country
8.1 Latin America Recombinant Peptide Historic Market Size by Country
8.1.1 Latin America Recombinant Peptide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Recombinant Peptide Sales in Volume by Country (2018-2023)
8.1.3 Latin America Recombinant Peptide Sales in Value by Country (2018-2023)
8.2 Latin America Recombinant Peptide Forecasted Market Size by Country
8.2.1 Latin America Recombinant Peptide Sales in Volume by Country (2024-2029)
8.2.2 Latin America Recombinant Peptide Sales in Value by Country (2024-2029)
9 Middle East and Africa Recombinant Peptide by Country
9.1 Middle East and Africa Recombinant Peptide Historic Market Size by Country
9.1.1 Middle East and Africa Recombinant Peptide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Recombinant Peptide Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Recombinant Peptide Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Recombinant Peptide Forecasted Market Size by Country
9.2.1 Middle East and Africa Recombinant Peptide Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Recombinant Peptide Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sandoz Pharma
10.1.1 Sandoz Pharma Company Information
10.1.2 Sandoz Pharma Introduction and Business Overview
10.1.3 Sandoz Pharma Recombinant Peptide Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sandoz Pharma Recombinant Peptide Products Offered
10.1.5 Sandoz Pharma Recent Development
10.2 Stada Arzneimittel
10.2.1 Stada Arzneimittel Company Information
10.2.2 Stada Arzneimittel Introduction and Business Overview
10.2.3 Stada Arzneimittel Recombinant Peptide Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Stada Arzneimittel Recombinant Peptide Products Offered
10.2.5 Stada Arzneimittel Recent Development
10.3 Amgen
10.3.1 Amgen Company Information
10.3.2 Amgen Introduction and Business Overview
10.3.3 Amgen Recombinant Peptide Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Amgen Recombinant Peptide Products Offered
10.3.5 Amgen Recent Development
10.4 Hospira
10.4.1 Hospira Company Information
10.4.2 Hospira Introduction and Business Overview
10.4.3 Hospira Recombinant Peptide Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Hospira Recombinant Peptide Products Offered
10.4.5 Hospira Recent Development
10.5 Actavis
10.5.1 Actavis Company Information
10.5.2 Actavis Introduction and Business Overview
10.5.3 Actavis Recombinant Peptide Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Actavis Recombinant Peptide Products Offered
10.5.5 Actavis Recent Development
10.6 Cipla Ltd.
10.6.1 Cipla Ltd. Company Information
10.6.2 Cipla Ltd. Introduction and Business Overview
10.6.3 Cipla Ltd. Recombinant Peptide Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Cipla Ltd. Recombinant Peptide Products Offered
10.6.5 Cipla Ltd. Recent Development
10.7 Wockhardt Ltd.
10.7.1 Wockhardt Ltd. Company Information
10.7.2 Wockhardt Ltd. Introduction and Business Overview
10.7.3 Wockhardt Ltd. Recombinant Peptide Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Wockhardt Ltd. Recombinant Peptide Products Offered
10.7.5 Wockhardt Ltd. Recent Development
10.8 Biocon Ltd.
10.8.1 Biocon Ltd. Company Information
10.8.2 Biocon Ltd. Introduction and Business Overview
10.8.3 Biocon Ltd. Recombinant Peptide Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Biocon Ltd. Recombinant Peptide Products Offered
10.8.5 Biocon Ltd. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Recombinant Peptide Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Recombinant Peptide Industrial Chain Analysis
11.4 Recombinant Peptide Market Dynamics
11.4.1 Recombinant Peptide Industry Trends
11.4.2 Recombinant Peptide Market Drivers
11.4.3 Recombinant Peptide Market Challenges
11.4.4 Recombinant Peptide Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Recombinant Peptide Distributors
12.3 Recombinant Peptide Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer